Diffuse Large B-cell Lymphoma Arising in Nodular Lymphocyte Predominant Hodgkin Lymphoma: a Report of 21 Cases from the Nebraska Lymphoma Study Group

References

• Poppema, S. (1992) "Lymphocyte-predominance Hodgkin's dis-ease", Seminars in Diagnostic Pathology, 9, 257–264.
   Google Scholar
• Chan, W.C. (1999) "Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and mole-cular studies", Seminars in Hematology, 36, 242–252.
   Google Scholar
• Pappa, V.I., Norton, A.J., Gupta, R.K., Wilson, A.M., Rohatiner, A.Z. and Lister, T.A. (1995) "Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases", Annals of Oncology, 6, 559–565.
   Google Scholar
• Sextro, M., Diehl, V., Franklin, J., Hansmann, ML., Anagnosto-poulos, I., Marafioti, T. and Stein, H. (1996) "Lymphocyte predominant Hodgkin's disease—a workshop report from the European Task Force on Lymphoma", Annals of Oncology, 7, 61 —65.
   Google Scholar
• Diehl, V., Sextro, M., Franklin, J., Hansmann, ML., Harris, N., Jaffe, E., et al. (1999) "Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lympho-cyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease", Journal of Clinical Oncology, 17, 776–783.
   Google Scholar
• Ha, CS., Kavadi, V., Dimopoulos, M.A.Hagemeister, F.B., Osborne, B.M., Fuller, L.M., et al. (1999) "Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria", International Journal of Radiation, Oncol-ogy, Biology, Physics, 43, 329–334.
   Google Scholar
• Miettinen, M., Franssila, K.O. and Saxen, E. (1983) "Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas", Cancer, 51, 2293–2300.
   Google Scholar
• Hansmann, ML., Zwingers T., Boske, A., Loftier, H. and Lennert, K. (1984) "Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular)", Journal of Cancer Research and Clinical Oncology, 108, 321–330.
   Google Scholar
• Toner, G.C., Sinclair, R.A., Sutherland, R.C. and Schwarz, M.A. (1986) "Composite lymphoma", American Journal of Clinical Pathology, 86, 375–378.
   Google Scholar
• Sundeen, J.T., Cossman, J. and Jaffe, ES. (1988) "Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent 'large cell lymphoma'. Histological progression or composite malignancy?", Amerian Journal Surgical Pathology, 12, 599–606.
   Google Scholar
• Hansmann, ML., Stein, H., Fellbaum, C., Hui, P.K., Parwaresch, M.R. and Lennert, K. (1989) "Nodular paragranuloma can transform into high-grade malignant lymphoma of B type", Human Pathology, 20, 1169–1175.
   Google Scholar
• Grossman, D.M., Hanson, C.A. and Schnitzer, B. (1991) "Simulta-neous lymphocyte predominant Hodgkin's disease and large-cell lymphoma". American Journal Surgical Pathology, 15, 668–676.
   Google Scholar
• Jaffe, ES., Zarate-Osorno, A., Kingma, D.W., Raffeld, M. and Medeiros, L.J. (1994) "The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas", Annals of Oncology, 5,7 —11.
   Google Scholar
• Bennett, M.H., MacLennan, K.A., Vaughan Hudson G., et al. (1991) "Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation", Annals of Oncology, 2\(Suppl 2), 83–92.
   Google Scholar
• Wickert, R.S., Weisenburger, D.D., Tierens A., Greiner, T.C. and Chan, W.C. (1995) "Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage", Blood, 86, 2312–2320.
   Google Scholar
• Hell, K., Hansmann, ML., Pringle, J.H., Lauder, I. and Fischer, R. (1995) "Combination of Hodgkin's disease and diffuse large cell lymphoma: an in situ hybridization study for immunoglobulin light chain messenger RNA", Histopathology, 27, 91–499.
   Google Scholar
• Greiner, T.C., Gascoyne, RD., Anderson, ME., Kingma, D.W., Adomat, S.A., Said, J. and Jaffe, E.S. (1996) "Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lympho-ma: analysis of Ig gene rearrangements by V-J polymerase chain reaction", Blood, 88, 657–666.
   Google Scholar
• Ohno, T., Huang, J.Z., Wu G., Wu, G., Weisenburger, D.D. and Chan, W.C. (2001) "The tumor cells in nodular lymphocyte-predominant Hodgkin disease are clonally related to the large cell lymphoma occurring in the same individual. Direct demonstration by single cell analysis", American Journal of Clinical Pathology, 116, 506 — 511.
   Google Scholar
• Kroft, S.H. (2001) "Lymphoma transformation: genetic relatedness, stealth lymphomas, and the final frontier", American Journal of Clinical Pathology, 116, 811 — 814.
   Google Scholar
• Kim, H., Hendrickson, R. and Dorfman, R.F. (1977) "Composite lymphoma", Cancer, 40, 959–976.
   Google Scholar
• Whittaker, M., Fomcar, K., Keith, T. and McAneny, B. (1989) "Simultaneous nodular lymphocyte predominance Hodgkin's dis-ease (N-LPHD) and large-cell lymphoma (LCL)", American Journal Surgical Pathology, 13, 715–716.
   Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project. (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 32,987–994.
   Google Scholar
• Vose, J.M. (1995) "CHLVPP therapy for Hodgkin's disease identification of prognostic factors", Leukemia and Lymphoma, 15\(Suppl 1), 13–14.
   Google Scholar
• Pavlovsky, S., Santarelli, MT., Erazo, A., Diaz Maqueo, J.C., Somoza, N., Lluesma Gonalons, M., et al. (1992) "Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP", Annals of Oncology, 3, 205–209.
   Google Scholar
• Andrieu, J.M., Yilmaz, U. and Colonna, P. (1999) "MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians", Journal of Clinical Oncology, 17, 730–734.
   Google Scholar
• Schouten, H.C., Sanger, W.G., Weisenburger, D.D., Anderson, J. and Armitage J.0. (1990) "Chromosomal abnormalities in un-treated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome", The Nebraska Lymphoma Study Group, Blood, 75, 1841–1847
   Google Scholar
• Vose, J.M., Anderson, JR., Bierman, P.J., Bast, M., Weisenburger, D., Chan, W.C., et al. (1994) "Comparison of front-line chemother-apy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens", The Nebraska Lymphoma Study Group, Seminars in Hematology, 31, 4–8.
   Google Scholar
• Velasquez, W.S., Cabanillas, F., Salvador, P., McLaughlin, P., Fridrik, M., Tucker, S., et al. (1988) "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)", Blood, 71, 117–122.
   Google Scholar
• Fields, K.K., Zorsky, P.E., Hiemenz, J.W., Kronish, L.E. and Elfenbein, G.J. (1994) "Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity", Journal of Clinical Oncology, 12, 544— 552.
   Google Scholar
• Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., et a/..(1994) "ESHAP— an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study", Journal of Clinical Oncology, 12, 1169–1176.
   Google Scholar
• Prokocimer, M., Modan, M., Rusoshansky, S., Bairey, 0. and Shaklai, M. (1989) "ProMACE-CytaBOM: combination che-motherapy for diffuse large cell lymphoma", Anticancer Research, 9, 1233–1235.
   Google Scholar
• Salar, A., Sierra, J., Gandarillas, M., Caballero, M.D., Mann, J., Lahuerta, ii., et al. (2001) "Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens", Bone Marrow Transplant, 27, 405–412.
   Google Scholar
• Kessinger, A., Vose, J.M., Bierman, P.J., Bishop M. and Armitage, J.0. (1993) "Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients", Journal of Hematotherapy, 2, 361–362.
   Google Scholar
• Armitage J.0. (1990) "Bone marrow transplantation in the treatment of lymphoma", Current Opinion in Oncology, 2, 843–848.
   Google Scholar
• Cheson, B.D., Horning, Si., Coiffier, B., Shipp, M.A., Fisher, RI., Connors, J.M., et al. (1999) "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas", NCI Sponsored International Working Group, Journal of Clinical Oncology, 17, 1244.
   Google Scholar
• Raine, L.S.M. and Fanger, H. (1981) "Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) proce-dures", Journal Histochem Cytochem, 29, 577–580.
   Google Scholar
• Kaplan, E. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", Journal of the American Statistical Association, 53, 457–481.
   Google Scholar
• Cox, J.D. and Stoffel, T.J. (1980) "Clinical versus pathologic stage I and II Hodgkin's disease", Oncology, 37, 325— 328.
   Google Scholar
• Mittal, B.B. and Nalesnik, M. (1986) "Composite lymphoma (Hodgkin's and non-Hodgkin's) of the spleen in a previously untreated patient", Acta Haematologica, 76, 29–32.
   Google Scholar
• Rudiger, T., Gascoyne, RD., Jaffe, ES., de Jong, D., Delabie, J., De Wolf-Peeters, C., et al. (2002) "Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma", Annals of Oncology, 13\(Suppl 1), 44–51.
   Google Scholar